Intervention:
Nutrafol Women’s Balance (n = 40) or placebo (n = 30). Assessments at Days 0, 90 and 180 using standardized macrophotography/phototrichogram for terminal, vellus and total hair counts.
Study duration: 180 days
Eligibility Criteria:
For more, plus the exclusion criteria, see:
Terminal Hair Counts: Nutrafol Women's Balance significantly increased terminal hair counts by 4.3% and 10.2% after 90 and 180 days of treatment, respectively (P<0.01 for both, relative to placebo).
Total Hair Counts: Nutrafol Women's Balance significantly increased total hair counts by 3.7% and 9.97% after 90 and 180 days of treatment, respectively (P<0.01 for both, relative to placebo).
Vellus Hair Counts: Nutrafol Women's Balance significantly increased vellus hair counts by 10.78% after 180 days of treatment (P<0.05, relative to placebo).
Hair shedding: Nutrafol Women's Balance significantly reduced hair shedding - cumulating in a decrease of -32.41% (P<0.01) after 180 days of treatment. The placebo group exhibited a -10.08% reduction in shedding (statistically insignificant).
Blinded Investigator Global Hair Assessments: A significantly greater proportion of subjects in the Nutrafol Women's Balance group recorded global hair growth improvement ratings (P<0.005) after 180 days of treatment, compared to placebo (73% and 22% for Women's Balance and placebo groups, respectively).
This information is provided as a medical and scientific educational resource for the use of dieticians and other licensed healthcare professionals. This information is intended for Practitioners to use as the basis for determining whether to recommend these products to their clients. All recommendations regarding protocols, dosing, prescribing and/or use instructions should be tailored to the individual needs of the client considering their medical history and concomitant therapies. This Information is not intended for use by consumers.
© 2025 Unilever.
All rights reserved
